comprehensive -WSS

comprehensive

author：comprehensive 2025-10-01 11:45:57 - browse：29712

This is the online edition of Adam’s Biotech Scorecard, a new subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered every Thursday to their inbox.

Hello, friends! I’m in San Francisco for the STAT Breakthrough Summit. Later today, I’ll be “fireside chatting” with Cytokinetics CEO Robert Blum. It’s not too late to join us virtually. Check out details here.

It’s a travel-shortened week for me, so in this newsletter, I decided to dive deep into PDS Biotech and its experimental drug for head and neck cancer. PDS is what I’d call a biotech cult stock.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： DeSantis wants to import drugs. Biden’s FDA blasted his plan

explore

WSS

Experimental asthma app from Apple and Anthem shows promise

Former Pear Therapeutics executives start new VC firm

Can U.S. cancer drug shortages be fixed?

Publishing genetic code of viruses could cause disaster

Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.

Study: Spinal cord stimulation helps patients with paralysis walk again

leisure time

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

hotspot

Medicare details structure of new drug price negotiation program

Drugmakers bet big on mRNA for cancer. Why's Biden going in?

Peter Hotez and the public health issue of online harassment

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

ChatGPT in medicine: STAT answers readers' burning questions

Can U.S. cancer drug shortages be fixed?

ChatGPT in medicine: STAT answers readers' burning questions

Readout Newsletter: Zepbound, Valneva's vaccine, and more

Apple is now the first public company to be valued at $3 trillion

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

hotspot

UnitedHealth sued over use of algorithm in Medicare Advantage plans

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

How the first Native Hawaiian psychiatrist helped diversify medicine

FDA advisory panel to debate high blood pressure devices

Ohio still needs to do more to protect the right to abortion

Today's health inequities arise from racist U.S. history, say experts

explore

explore

leisure time

entertainment